The latest news about RNA-seq, gene expression profiling, and transcriptome sequencing.
NCI researchers performed a multi-platform study to elucidate the factors that can contribute to a patient's better-than-expected response to a drug.
Illumina Ventures led the round for the Santa Clara, California-based firm, which is developing applications for its optical detection technology.
The atlas further enabled researchers to uncover the molecular state of cells, identify the targets of circulating hormones, and determine the cells affected by disease genes or viruses.
CPTAC researchers analyzed the genomes, proteomes, phosphoproteomes, and acetylproteomes of 122 treatment-naive breast cancer samples.
Developed by researchers at Yale University, the method, called deterministic barcoding in tissue sequencing, can map thousands of genes at 10 micron resolution.
